Chronic inflammatory demyelinating polyradiculoneuropathy
Showing 1 - 25 of >10,000
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy Trial (Panzyga)
Not yet recruiting
- Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Sep 2, 2022
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Durham, North CarolinaRTI Health Solutions
Jun 14, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Multifocal Motor Neuropathy (MMN)
-
Nagoya, Aichi, Japan
- +16 more
Feb 2, 2023
Intravenous Immunoglobulin Treatment in Chronic Inflammatory
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Vasculitic Neuropathy (Disorder) Trial in
Active, not recruiting
- Peripheral Neuropathy
- +5 more
- Biopsy + Nerve Repair
- Biopsy Only
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 25, 2023
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Scottsdale, Arizona
- +13 more
Mar 31, 2022
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A
Recruiting
- Autoimmune Diseases
- +5 more
- CT103A cells
- Cyclophosphamide and fludarabine
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022
Disease Activity in Chronic Inflammatory Demyelinating
Recruiting
- CIDP
- Smartwatch (Withings Scanwatch)
-
Duesseldorf, Northrhine-Westphalia, GermanyMedical Faculty, Heinrich-Heine-University
Feb 1, 2023
RWE-based Treatment Patterns and Outcomes in CIDP
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- +2 more
- No intervention. Retrospective observation only.
-
Salford, United KingdomNorthern Care Alliance NHS Foundation Trust
Jul 7, 2023
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- VitalStim 400
- VitalStim400
-
Atlanta, GeorgiaCenter for Advanced Pediatrics, Children's Healthcare of Atlanta
Sep 2, 2022
Predict Intravenous Immunoglobulin Responders in Chronic
Suspended
- CIDP
- CIDP treated (IVIG)
-
Bordeaux, Aquitaine, France
- +17 more
Dec 23, 2021
High Frequency Ultrasound in Demyelinating Polyneuropathies
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- high frequency ultrasound
-
Nice, FranceNice University Hospital
Jul 28, 2021
Spinal Cord Injuries Trial in Sugar Land (HB-adMSCs)
No longer available
- Chronic Inflammatory Demyelinating Polyneuropathy
- HB-adMSCs
-
Sugar Land, TexasHope Biosciences Stem Cell Research Foundation
Sep 20, 2022
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Clinical examination, Functional scales, Walking test)
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Clinical examination
- +2 more
- (no location specified)
Aug 5, 2022
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Nice (Ultrasound UHF peripheral nerves, Electro myography
Completed
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Ultrasound UHF peripheral nerves
- Electro myography surface nerves
-
Nice, FranceCHU de Nice
May 5, 2022
Polyneuropathy, Impairments and Physical Activity - The
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- +8 more
- Validity and reliability of outcome measures in polyneuropathy
- Healthy controls
- (no location specified)
Sep 15, 2023
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
- +2 more
-
Boca Raton, Florida
- +1 more
Jan 31, 2023
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (SAR445088 (IV), SAR445088 (SC))
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- SAR445088 (IV)
- SAR445088 (SC)
-
Los Angeles, California
- +28 more
Aug 24, 2022
Clinical and Electrophysiological Patterns of Chronic Dysimmune
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Jan 20, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Rituximab (genetical recombination)
- Placebo
-
Nagoya, Aich, Japan
- +3 more
Aug 19, 2021
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune
Recruiting
- CIDP
- +2 more
- Intravenous immune globulin G
- Subcutaneous immune globulin G
-
New Brunswick, New JerseyRutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022
Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)
Withdrawn
- Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Nov 2, 2021
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA)
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- HYQVIA
-
Phoenix, Arizona
- +34 more
Mar 21, 2022
Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide
Recruiting
- Healthy
- +2 more
- PF-06755347 intravenous healthy participant
- +4 more
-
New Haven, Connecticut
- +5 more
Dec 29, 2022